AbbVie Inc
XETRA:4AB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
AbbVie Inc (4AB) under the Base Case is EUR per share.
Compared with the current market price of 270.4 EUR, the stock appears .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years.
Create a free account · No card needed
Fundamental Analysis
What AbbVie Does
AbbVie is a pharmaceutical company that develops and sells prescription medicines. Its business is built around branded drugs for conditions such as immune disorders, cancer, eye disease, and other serious illnesses. It also works on research and development to create new treatments and support its long-term drug portfolio.
- Headquarters
- United States of America US
- Employees
- 57 000
- IPO date
- Jan 2, 2013
AbbVie has a wide economic moat
Patents prevent rivals from copying AbbVie’s protected medicines and competing mainly on price. Protection across several treatments helps the company defend its profits without relying on a single drug.
Read the full moat analysisContinue 4AB Research
Decided on AbbVie? Get an email when 4AB reaches the price you’d buy at. Free with an account.
Other AbbVie listings
What is the Intrinsic Value of one 4AB stock?
The intrinsic value for
AbbVie Inc (4AB) under the Base Case is EUR.
Is 4AB stock undervalued or overvalued?
Compared with the current market price of 270.4 EUR, the stock appears .